Cannabis smoking

CannaVerde Pharma Signs Letter of Intent with Leading Colombian Pharmacy Medical Precision Care

Thursday, January 21, 2021 - 9:55pm

("Medical Precision"), a master pharmacy exclusively focused on the research and development of cannabis-based pharmaceutical products in Latin America.

Key Points: 
  • ("Medical Precision"), a master pharmacy exclusively focused on the research and development of cannabis-based pharmaceutical products in Latin America.
  • "This acquisition cements CannaVerde as one of the leading medical cannabis companies in Colombia and Latin America.
  • I have to commend our team, whose strong in-country relationships translated into an agreement with Medical Precision amidst competitive offers from other Colombian cannabis producers," commented CannaVerde CEO, Michael Nistorescu.
  • Medical Precision Care is a master pharmacy exclusively focused on research and development of cannabis-based pharmaceutical products in Latin America.

FlowerHire Presents the CareersinCannabis.com Virtual Talent Conference on January 28th

Thursday, January 21, 2021 - 2:00pm

LOS ANGELES, Jan. 21, 2021 /PRNewswire/ -- FlowerHire , the leading staffing and talent strategy firm serving the regulated cannabis industry, announced today the launch of its new platform, CareersinCannabis.com .

Key Points: 
  • LOS ANGELES, Jan. 21, 2021 /PRNewswire/ -- FlowerHire , the leading staffing and talent strategy firm serving the regulated cannabis industry, announced today the launch of its new platform, CareersinCannabis.com .
  • The specialized career portal equips both companies and job candidates with the tools and insights necessary to build a robust, quality workforce.
  • The service officially launches at the inaugural Careers in Cannabis virtual talent conference on January 28.
  • The website launches in conjunction with the Careers in Cannabis Virtual Talent Conference, focusing on the opportunities and challenges faced by executives and HR leaders in the fastest growing industry in the country.

American Cannabis Company, Inc. Announces Execution of Non-Binding Letter of Intent for Strategic Acquisition of a 60,000-sq.-ft. Cannabis Cultivation and Extraction Operation in Denver, Colorado

Thursday, January 21, 2021 - 1:30pm

Assets are to include one cultivation operation and one hydrocarbon extraction laboratory and production center.

Key Points: 
  • Assets are to include one cultivation operation and one hydrocarbon extraction laboratory and production center.
  • Since 2009, the Good Meds brand has cultivated and provided top-tier cannabis flower products to medical patients and recreational consumers in Colorado.
  • Terry Buffalo, Chief Executive Officer and Chief Financial Officer of American Cannabis Company, commented, This is another strategic move for ACC.
  • American Cannabis Company, Inc. offers end-to-end solutions to existing and aspiring participants in the cannabis and hemp industries.

CCSA and Health Canada Invest $1.8 Million in Cannabis Research Projects

Thursday, January 21, 2021 - 2:00pm

The Canadian Centre on Substance Use and Addiction (CCSA) is investing $1.8 million dollars in research on non-therapeutic cannabis and the impacts of its legalization on public health and safety throughout the country.

Key Points: 
  • The Canadian Centre on Substance Use and Addiction (CCSA) is investing $1.8 million dollars in research on non-therapeutic cannabis and the impacts of its legalization on public health and safety throughout the country.
  • Through financial support from Health Canada, CCSA is funding 19 projects on subjects ranging from cannabis legalization and mental health to a comparison of legal versus illicit cannabis sales.
  • The Mental Health Commission of Canada is contributing $100,000 to support awarded projects with a mental health focus for a combined research investment of $1.8 million.
  • As part of this initiative, CCSA created the Canadian Cannabis Research Database , an online tool capturing current and ongoing cannabis research activities in Canada.

Rapid Oral Fluid Screening Device Market Size USD 24.08 Billion By 2027 | CAGR: 20.7% : Polaris Market Research

Thursday, January 21, 2021 - 1:00pm

NEW YORK, Jan. 21, 2021 /PRNewswire/ -- The global rapid oral fluid screening device market size is predicted to reach USD 24.08 billion by 2027. according to a new study conducted by Polaris Market Research.

Key Points: 
  • NEW YORK, Jan. 21, 2021 /PRNewswire/ -- The global rapid oral fluid screening device market size is predicted to reach USD 24.08 billion by 2027. according to a new study conducted by Polaris Market Research.
  • Easy portability with better convenience makes strip a better choice compared to other rapid oral fluid screening devices
    Increasing R&D activities by manufacturers to create strong product pipelines of rapid oral fluid screening devices has boosted the overall development of the market.
  • Rapid oral fluid screening devices provide a wide range of screening abilities such as marijuana, cocaine, methamphetamine, and opioids are expected to drive rapid oral fluid screening device market growth over the forecast period.
  • Feel Free To Ask Our Industry Experts At : https://www.polarismarketresearch.com/industry-analysis/rapid-oral-fluid...
    Polaris Market Research has segmented the rapid oral fluid screening device market report on the basis of drug type, form, end-use, and region
    Global Rapid Oral Fluid Screening Device Market, By Drug Type (Revenue USD Million, 2016 2027)

Biotech Is Fueling An All-New Cannabis Boom

Thursday, January 21, 2021 - 1:00pm

A New Path for Safe, Effective Treatments

Key Points: 
  • A New Path for Safe, Effective Treatments
    The start of this massive boom began in California, when they legalized medical marijuana with overwhelming support in 1996.
  • Since then, dozens of other states and entire nations have jumped onboardAnd the global cannabis industry is expected to reach an incredible $57 billion by 2025.
  • The Scotts Miracle-Gro Company (NYSE:SMG) is a rather unique way to play the cannabis boom.
  • The Ontario-based cannabis company has operations in more than 10 countries and distributes medical cannabis across the globe.

Biotech Is Fueling An All-New Cannabis Boom

Thursday, January 21, 2021 - 1:00pm

A New Path for Safe, Effective Treatments

Key Points: 
  • A New Path for Safe, Effective Treatments
    The start of this massive boom began in California, when they legalized medical marijuana with overwhelming support in 1996.
  • Since then, dozens of other states and entire nations have jumped onboardAnd the global cannabis industry is expected to reach an incredible $57 billion by 2025.
  • The Scotts Miracle-Gro Company (NYSE:SMG) is a rather unique way to play the cannabis boom.
  • The Ontario-based cannabis company has operations in more than 10 countries and distributes medical cannabis across the globe.

LeafLink Recognizes Plus Products’ Sour Watermelon UPLIFT as Best-Selling California Edible for 2020

Thursday, January 21, 2021 - 12:45pm

SAN MATEO, Calif., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) (the Company or PLUS), a cannabis and hemp branded products company in the U.S., today announced that its Sour Watermelon UPLIFTgummies were recognized as LeafLink's best-selling cannabis edible in the California market and one of the five best-selling edible products across all active markets.

Key Points: 
  • SAN MATEO, Calif., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) (the Company or PLUS), a cannabis and hemp branded products company in the U.S., today announced that its Sour Watermelon UPLIFTgummies were recognized as LeafLink's best-selling cannabis edible in the California market and one of the five best-selling edible products across all active markets.
  • Connecting over 1,700 cannabis brands with over 5,600 licensed retailers, the LeafLink platform is active in 26 legal markets across North America.
  • PLUS is thrilled to see one of our products receive such noteworthy recognition, stated Jake Heimark, PLUS Co-founder and CEO.
  • PLUS Sour Watermelon UPLIFT, with over 38 million gummies sold since January 2018, has remained one of the most popular cannabis products in California since adult-use was legalized.1
    The LeafLink List 2020 was created by analyzing orders through the LeafLink marketplace from January 1st, 2020 to September 1st, 2020.

European Union Intellectual Property Office grants Powered by HEXO registered trademark status

Thursday, January 21, 2021 - 11:30am

OTTAWA, Jan. 21, 2021 (GLOBE NEWSWIRE) -- HEXO Corp. (HEXO, or the Company) (TSX: HEXO; NYSE: HEXO) is pleased to announce that following a two-year process, its trademark Powered by HEXO has been registered with the European Union Intellectual Property Office.

Key Points: 
  • OTTAWA, Jan. 21, 2021 (GLOBE NEWSWIRE) -- HEXO Corp. (HEXO, or the Company) (TSX: HEXO; NYSE: HEXO) is pleased to announce that following a two-year process, its trademark Powered by HEXO has been registered with the European Union Intellectual Property Office.
  • Receiving registered trademark status in the EU supports our ongoing Powered by HEXO strategy and enhances the global value of our brand, said HEXO CEO and co-founder Sebastien St-Louis.
  • Powered by HEXO brings best-in-class research and technology, regulatory expertise and superior ingredients together with product knowledge, deep consumer understanding and established global distribution networks.
  • The Company serves the Canadian adult-use markets under its HEXO Cannabis, Up Cannabis and Original Stash brands, and the medical market under HEXO medical cannabis.

Canada Coal Announces Ayurcann Receipt of Amendment to Standard Processing Licence to Allow for Sales

Wednesday, January 20, 2021 - 4:04pm

TORONTO, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Canada Coal Inc. (Canada Coal or the Company) (TSXV: CCK.H) is pleased to announce that Ayurcann Inc. d.b.a XTRX Solutions Inc. (Ayurcann) has obtained an amendment to its standard processing licence (the Amended Licence) from Health Canada which allows Ayurcann to sell extracts, edibles, and topical products directly to provincial and territorial retailers across Canada.

Key Points: 
  • TORONTO, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Canada Coal Inc. (Canada Coal or the Company) (TSXV: CCK.H) is pleased to announce that Ayurcann Inc. d.b.a XTRX Solutions Inc. (Ayurcann) has obtained an amendment to its standard processing licence (the Amended Licence) from Health Canada which allows Ayurcann to sell extracts, edibles, and topical products directly to provincial and territorial retailers across Canada.
  • Ayurcann concentrates on the post-harvest requirements of licensed cannabis producers and other brands looking to enter the cannabis market.
  • The information about Ayurcann contained in the press release has not been independently verified by Canada Coal.
  • Canada Coal and Ayurcann caution that the foregoing list of material factors is not exhaustive.